Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C1784
http://purl.obolibrary.org/obo/NCIT_C1784
|
|---|---|
| Preferred Name | Oregovomab |
| Definitions |
A murine monoclonal antibody that attaches to the tumor-associated antigen CA125. Vaccination with monoclonal antibody B43.13 may stimulate a host cytotoxic immune response against tumor cells that express CA125. (NCI04)
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A murine monoclonal antibody that attaches to the tumor-associated antigen CA125. Vaccination with monoclonal antibody B43.13 may stimulate a host cytotoxic immune response against tumor cells that express CA125. (NCI04) |
|---|---|
| prefLabel | Oregovomab
|
| label | Oregovomab
|
| PDQ_Closed_Trial_Search_ID | 43251
|
| code | C1784
|
| Has_Target | |
| prefixIRI | NCIT:C1784
|
| in_subset |
See more
See less
|
| Display_Name | Oregovomab
|
| Preferred_Name | Oregovomab
|
| FDA_UNII_Code | HX101E7L6S
|
| Contributing_Source |
CTRP
FDA
|
| Maps_To | Oregovomab
|
| CAS_Registry | 213327-37-8
|
| NCI_Drug_Dictionary_ID | 43251
|
| Legacy Concept Name | Monoclonal_Antibody_B43_13
|
| type | |
| ALT_DEFINITION | A monoclonal antibody that is being studied in the treatment of ovarian cancer. Monoclonal antibodies are made in the laboratory and can locate and bind to substances in the body, including cancer cells. Oregovomab binds to the CA-125 antigen, which is found on most ovarian cancer cells.
|
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 43251
|
| Accepted_Therapeutic_Use_For | Epithelial ovarian cancer
|
| Semantic_Type |
Amino Acid, Peptide, or Protein
Pharmacologic Substance
Immunologic Factor
|
| UMLS_CUI | C0664207
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |